GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (LTS:0K9H) » Definitions » EV-to-FCF

Faes Farma (LTS:0K9H) EV-to-FCF : (As of May. 23, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Faes Farma EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Faes Farma's Enterprise Value is €1,126.2 Mil. Faes Farma's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 was €0.0 Mil. Therefore, Faes Farma's EV-to-FCF for today is .

The historical rank and industry rank for Faes Farma's EV-to-FCF or its related term are showing as below:

LTS:0K9H' s EV-to-FCF Range Over the Past 10 Years
Min: -913.44   Med: 0   Max: 56.17
Current: -913.44

During the past 13 years, the highest EV-to-FCF of Faes Farma was 56.17. The lowest was -913.44. And the median was 0.00.

LTS:0K9H's EV-to-FCF is ranked worse than
100% of 524 companies
in the Drug Manufacturers industry
Industry Median: 25.35 vs LTS:0K9H: -913.44

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Faes Farma's stock price is €3.69. Faes Farma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €0.283. Therefore, Faes Farma's PE Ratio for today is 13.04.


Faes Farma EV-to-FCF Historical Data

The historical data trend for Faes Farma's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faes Farma EV-to-FCF Chart

Faes Farma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.82 17.11 47.62 39.24 -787.44

Faes Farma Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 39.24 - - -

Competitive Comparison of Faes Farma's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Faes Farma's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Faes Farma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Faes Farma's EV-to-FCF falls into.



Faes Farma EV-to-FCF Calculation

Faes Farma's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1126.209/0
=

Faes Farma's current Enterprise Value is €1,126.2 Mil.
Faes Farma's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Faes Farma  (LTS:0K9H) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Faes Farma's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.69/0.283
=13.04

Faes Farma's share price for today is €3.69.
Faes Farma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.283.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Faes Farma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Faes Farma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Faes Farma (LTS:0K9H) Business Description

Traded in Other Exchanges
Address
Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma (LTS:0K9H) Headlines

No Headlines